Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like

Yusuke Motoji1, Ryuji Fukazawa2, Ryosuke Matsui2

  • 1Department of Cardiovascular Surgery, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.

Insights

Kawasaki disease (KD) causes vascular inflammation and damage. Statins may prevent cardiovascular issues by restoring endothelial cell function and nitric oxide synthase expression in KD patients.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pharmacology

Background:

  • Kawasaki disease (KD) is an acute inflammatory syndrome linked to cardiovascular complications.
  • Chronic KD-induced vasculitis may lead to atherosclerosis in young adults via cellular senescence and endothelial damage.

Purpose of the Study:

  • To investigate the impact of KD and statin treatment on vascular cellular senescence and endothelial cells.
  • To assess statins' potential in mitigating KD-related vascular damage.

Main Methods:

  • Kawasaki disease-like vasculitis was induced in apolipoprotein E-deficient mice using Candida albicans water-soluble fraction (CAWS).
  • Mice were divided into control, CAWS, and CAWS+statin groups.
  • Aortic tissues were analyzed for endothelial nitric oxide synthase (eNOS) expression and cellular senescence markers.

Main Results:

  • KD-like vasculitis impaired eNOS-producing vascular endothelial cells and increased macrophage infiltration.
  • Statins treatment restored endothelial cell function by enhancing eNOS expression.
  • Cellular senescence markers were modulated by KD and statin treatment.

Conclusions:

  • KD-induced vasculitis damages vascular endothelial cells and promotes inflammation.
  • Statins demonstrate potential in restoring endothelial function and may prevent chronic cardiovascular events post-KD.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
747
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34